$IPCI Company News
Flamel Technologies (FLML) Jumps: Stock Adds 9.8% in Session - Tale of the Tape 8:51 a.m. April 10, 2014 - Zacks.com
Catalyst Pharmaceutical Partners Inc. (CPRX) Jumps: Stock Up 8.6% - Tale of the Tape 8:51 a.m. April 4, 2014 - Zacks.com
Corcept Therapeutics (CORT) Jumps: Stock Adds 5.4% in Session - Tale of the Tape 9:39 a.m. March 31, 2014 - Zacks.com
IntelliPharmaCeutics International (IPCI) Soars: Stock Rises 9.1% - Tale of the Tape 8:51 a.m. March 21, 2014 - Zacks.com
Can the Rally in IntelliPharmaCeutics (IPCI) Shares Continue? - Tale of the Tape 7:44 a.m. March 21, 2014 - Zacks.com
IntelliPharmaCeutics (IPCI) Jumps: Stock Up 8.9% - Tale of the Tape 8:51 a.m. March 11, 2014 - Zacks.com
Strong Demand For Resistance Technology Bodes Well For IntelliPharmaCeutics 1:06 p.m. Dec. 17, 2013 - Seeking Alpha
Thursday’s Biggest Stock Losers: SGOC, VJET, and More 5:56 a.m. Nov. 21, 2013 - InvestorPlace.com
Strength Seen in IntelliPharmaCeutics (IPCI): Stock Shoots 161.9% - Tale of the Tape 10:04 a.m. Nov. 20, 2013 - Zacks.com
Small Cap Stocks: Why IPCI Stock Went Bonkers 3:45 a.m. Nov. 20, 2013 - InvestorPlace.com
Alcatel-Lucent Left in the Lurch by Nokia and 2 More Heavily Traded Stocks to Follow 5:14 p.m. Nov. 19, 2013 - Wall St. Cheat Sheet
Intellipharmaceutics still Buy-rated following Focalin XR generic news 11:05 a.m. Nov. 19, 2013 - Seeking Alpha
Intellipharmaceutics nearly doubles on generic Focalin XR approval 9:31 a.m. Nov. 19, 2013 - Seeking Alpha
Intellipharmaceutics Reports Loss - Analyst Blog 2:15 p.m. Oct. 7, 2013 - Zacks.com
IntelliPharmaCeutics Sell Off On Acura Data Overdone... Compelling Entry Point 7:25 a.m. Aug. 28, 2013 - Seeking Alpha
IntelliPharmaCeutics Sell Off On ACUR Data Overdone... Compelling Entry Point 7:25 a.m. Aug. 28, 2013 - Seeking Alpha
IPCI Sell Off On ACUR Data Overdone...Compelling Entry Point 7:25 a.m. Aug. 28, 2013 - Seeking Alpha
IntelliPharmaCeutics - Primed For An Easy Double 6:07 a.m. Aug. 22, 2013 - Seeking Alpha
Intellipharmaceutics Announces Pricing of Public Offering of 1.5 Million Common Shares and Warrants 8:31 a.m. July 26, 2013 - benzinga.com
Intellipharmaceutics Files Shelf Registration 4:55 a.m. July 26, 2013 - benzinga.com
Reviewing the Top Health Care Equities -- Research on IntelliPharmaCeutics, Delcath Systems, Valeant Pharma and Alkermes 5:39 p.m. March 21, 2014 - PR Newswire - PRF
Intellipharmaceutics -- Amended Form of Proxy for Shareholders Meeting to be Held on March 27, 2014 5:00 p.m. March 19, 2014 - GlobeNewswire
Approvals, Clinical Trial Results, Stock Summaries, Data Publication and Conference Participation - Analyst Notes on Northwest, La Jolla Pharma, Merrimack Pharma, Rosetta, and IntelliPharmaCeutics 8:20 a.m. March 13, 2014 - PR Newswire - PRF
Intellipharmaceutics to Present at Two Upcoming Investor Conferences 6:00 p.m. March 4, 2014 - GlobeNewswire
Intellipharmaceutics Announces 2013 Year End Results 8:05 a.m. Feb. 18, 2014 - GlobeNewswire
Biotech News for Advancing Pharma Stocks: Company's Test Results Surpass Expectations For $3.5 Billion ADHD Market 10:05 a.m. Feb. 4, 2014 - PR Newswire - PRF
Intellipharmaceutics Receives $3.1 Million From Par Pharmaceuticals, Inc. 8:00 a.m. Feb. 3, 2014 - GlobeNewswire
Healthcare Sector Announces Voluntary Recalls, Scheduled Presentations and Offering Programs - Research Report on Baxter, Incyte, Horizon Pharma, POZEN, and IntelliPharmaCeutics 9:00 a.m. Dec. 2, 2013 - PR Newswire
Intellipharmaceutics to Present at the 25th Annual Piper Jaffray Healthcare Conference 8:00 a.m. Dec. 2, 2013 - GlobeNewswire
Intellipharmaceutics Announces At-The-Market Offering of Common Shares 5:30 p.m. Nov. 27, 2013 - GlobeNewswire
Approved Acquisition, FDA Approvals, Senior Note Offerings, and Announcements by Drug Delivery Companies - Research Report on Elan, IntelliPharmaCeutics, Valeant Pharmaceuticals, Hospira, and Alkermes 9:00 a.m. Nov. 22, 2013 - PR Newswire
TrendingWallStreet.com Releases Trend Research on NNRX, NWBO, FMCC, and IPCI 1:17 a.m. Nov. 21, 2013 - ACCESSWIRE
TrendingWallStreet.com Releases Volume Coverage on NCT, VEND, PGLO, and IPCI 1:20 a.m. Nov. 20, 2013 - ACCESSWIRE
HZNP, FB, GRPN and IPCI added to NASDAQ Active Stock Watch List at GSR 11:11 a.m. Nov. 19, 2013 - ACCESSWIRE
Intellipharmaceutics / Par to Make Immediate Commercial Launch of 15 and 30 mg Generic Focalin XR(R) 5:35 p.m. Nov. 18, 2013 - GlobeNewswire
Intellipharmaceutics Announces Third Quarter 2013 Results 5:00 p.m. Oct. 1, 2013 - GlobeNewswire
Intellipharmaceutics Closes Public Offering for US$3.1 Million 5:25 p.m. July 31, 2013 - GlobeNewswire
Intellipharmaceutics Announces Pricing of Public Offering of Common Shares and Warrants 9:30 a.m. July 26, 2013 - GlobeNewswire
Intellipharmaceutics Announces Proposed Public Offering of Units of Common Shares and Warrants 2:07 a.m. July 26, 2013 - GlobeNewswire
Intellipharmaceutics Updates Developments on Its Rexista(TM) Oxycodone Technology 7:00 a.m. July 15, 2013 - GlobeNewswire
Flamel Technologies (FLML) Jumps: Stock Adds 9.8% in Session - Tale of the Tape 8:51 a.m. April 10, 2014 - Zacks.com
Catalyst Pharmaceutical Partners Inc. (CPRX) Jumps: Stock Up 8.6% - Tale of the Tape 8:51 a.m. April 4, 2014 - Zacks.com
Corcept Therapeutics (CORT) Jumps: Stock Adds 5.4% in Session - Tale of the Tape 9:39 a.m. March 31, 2014 - Zacks.com
IntelliPharmaCeutics International (IPCI) Soars: Stock Rises 9.1% - Tale of the Tape 8:51 a.m. March 21, 2014 - Zacks.com
Can the Rally in IntelliPharmaCeutics (IPCI) Shares Continue? - Tale of the Tape 7:44 a.m. March 21, 2014 - Zacks.com
IntelliPharmaCeutics (IPCI) Jumps: Stock Up 8.9% - Tale of the Tape 8:51 a.m. March 11, 2014 - Zacks.com
Strong Demand For Resistance Technology Bodes Well For IntelliPharmaCeutics 1:06 p.m. Dec. 17, 2013 - Seeking Alpha
Thursday’s Biggest Stock Losers: SGOC, VJET, and More 5:56 a.m. Nov. 21, 2013 - InvestorPlace.com
Strength Seen in IntelliPharmaCeutics (IPCI): Stock Shoots 161.9% - Tale of the Tape 10:04 a.m. Nov. 20, 2013 - Zacks.com
Small Cap Stocks: Why IPCI Stock Went Bonkers 3:45 a.m. Nov. 20, 2013 - InvestorPlace.com
Alcatel-Lucent Left in the Lurch by Nokia and 2 More Heavily Traded Stocks to Follow 5:14 p.m. Nov. 19, 2013 - Wall St. Cheat Sheet
Intellipharmaceutics still Buy-rated following Focalin XR generic news 11:05 a.m. Nov. 19, 2013 - Seeking Alpha
Intellipharmaceutics nearly doubles on generic Focalin XR approval 9:31 a.m. Nov. 19, 2013 - Seeking Alpha
Intellipharmaceutics Reports Loss - Analyst Blog 2:15 p.m. Oct. 7, 2013 - Zacks.com
IntelliPharmaCeutics Sell Off On Acura Data Overdone... Compelling Entry Point 7:25 a.m. Aug. 28, 2013 - Seeking Alpha
IntelliPharmaCeutics Sell Off On ACUR Data Overdone... Compelling Entry Point 7:25 a.m. Aug. 28, 2013 - Seeking Alpha
IPCI Sell Off On ACUR Data Overdone...Compelling Entry Point 7:25 a.m. Aug. 28, 2013 - Seeking Alpha
IntelliPharmaCeutics - Primed For An Easy Double 6:07 a.m. Aug. 22, 2013 - Seeking Alpha
Intellipharmaceutics Announces Pricing of Public Offering of 1.5 Million Common Shares and Warrants 8:31 a.m. July 26, 2013 - benzinga.com
Intellipharmaceutics Files Shelf Registration 4:55 a.m. July 26, 2013 - benzinga.com
Reviewing the Top Health Care Equities -- Research on IntelliPharmaCeutics, Delcath Systems, Valeant Pharma and Alkermes 5:39 p.m. March 21, 2014 - PR Newswire - PRF
Intellipharmaceutics -- Amended Form of Proxy for Shareholders Meeting to be Held on March 27, 2014 5:00 p.m. March 19, 2014 - GlobeNewswire
Approvals, Clinical Trial Results, Stock Summaries, Data Publication and Conference Participation - Analyst Notes on Northwest, La Jolla Pharma, Merrimack Pharma, Rosetta, and IntelliPharmaCeutics 8:20 a.m. March 13, 2014 - PR Newswire - PRF
Intellipharmaceutics to Present at Two Upcoming Investor Conferences 6:00 p.m. March 4, 2014 - GlobeNewswire
Intellipharmaceutics Announces 2013 Year End Results 8:05 a.m. Feb. 18, 2014 - GlobeNewswire
Biotech News for Advancing Pharma Stocks: Company's Test Results Surpass Expectations For $3.5 Billion ADHD Market 10:05 a.m. Feb. 4, 2014 - PR Newswire - PRF
Intellipharmaceutics Receives $3.1 Million From Par Pharmaceuticals, Inc. 8:00 a.m. Feb. 3, 2014 - GlobeNewswire
Healthcare Sector Announces Voluntary Recalls, Scheduled Presentations and Offering Programs - Research Report on Baxter, Incyte, Horizon Pharma, POZEN, and IntelliPharmaCeutics 9:00 a.m. Dec. 2, 2013 - PR Newswire
Intellipharmaceutics to Present at the 25th Annual Piper Jaffray Healthcare Conference 8:00 a.m. Dec. 2, 2013 - GlobeNewswire
Intellipharmaceutics Announces At-The-Market Offering of Common Shares 5:30 p.m. Nov. 27, 2013 - GlobeNewswire
Approved Acquisition, FDA Approvals, Senior Note Offerings, and Announcements by Drug Delivery Companies - Research Report on Elan, IntelliPharmaCeutics, Valeant Pharmaceuticals, Hospira, and Alkermes 9:00 a.m. Nov. 22, 2013 - PR Newswire
TrendingWallStreet.com Releases Trend Research on NNRX, NWBO, FMCC, and IPCI 1:17 a.m. Nov. 21, 2013 - ACCESSWIRE
TrendingWallStreet.com Releases Volume Coverage on NCT, VEND, PGLO, and IPCI 1:20 a.m. Nov. 20, 2013 - ACCESSWIRE
HZNP, FB, GRPN and IPCI added to NASDAQ Active Stock Watch List at GSR 11:11 a.m. Nov. 19, 2013 - ACCESSWIRE
Intellipharmaceutics / Par to Make Immediate Commercial Launch of 15 and 30 mg Generic Focalin XR(R) 5:35 p.m. Nov. 18, 2013 - GlobeNewswire
Intellipharmaceutics Announces Third Quarter 2013 Results 5:00 p.m. Oct. 1, 2013 - GlobeNewswire
Intellipharmaceutics Closes Public Offering for US$3.1 Million 5:25 p.m. July 31, 2013 - GlobeNewswire
Intellipharmaceutics Announces Pricing of Public Offering of Common Shares and Warrants 9:30 a.m. July 26, 2013 - GlobeNewswire
Intellipharmaceutics Announces Proposed Public Offering of Units of Common Shares and Warrants 2:07 a.m. July 26, 2013 - GlobeNewswire
Intellipharmaceutics Updates Developments on Its Rexista(TM) Oxycodone Technology 7:00 a.m. July 15, 2013 - GlobeNewswire
